TW200715996A - Method of increasing the salivary sialic acid content in a mammal - Google Patents

Method of increasing the salivary sialic acid content in a mammal

Info

Publication number
TW200715996A
TW200715996A TW095114559A TW95114559A TW200715996A TW 200715996 A TW200715996 A TW 200715996A TW 095114559 A TW095114559 A TW 095114559A TW 95114559 A TW95114559 A TW 95114559A TW 200715996 A TW200715996 A TW 200715996A
Authority
TW
Taiwan
Prior art keywords
mammal
acid content
sialic acid
increasing
salivary
Prior art date
Application number
TW095114559A
Other languages
English (en)
Inventor
Robert J Mcmahon
Bing Wang
Jennie Brand-Miller
Original Assignee
Bristol Myers Squibb Co
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Univ Sydney filed Critical Bristol Myers Squibb Co
Publication of TW200715996A publication Critical patent/TW200715996A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095114559A 2005-04-29 2006-04-24 Method of increasing the salivary sialic acid content in a mammal TW200715996A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/118,845 US20060246146A1 (en) 2005-04-29 2005-04-29 Method of increasing the salivary sialic acid content in a mammal

Publications (1)

Publication Number Publication Date
TW200715996A true TW200715996A (en) 2007-05-01

Family

ID=36607359

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095114559A TW200715996A (en) 2005-04-29 2006-04-24 Method of increasing the salivary sialic acid content in a mammal

Country Status (3)

Country Link
US (1) US20060246146A1 (zh)
TW (1) TW200715996A (zh)
WO (1) WO2006118701A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120095371A (ko) * 2009-10-01 2012-08-28 에보닉 데구사 코포레이션 노화 황반변성 치료용 극미립자 조성물들 및 노화 황반변성 치료방법
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
BR112013015951A2 (pt) 2010-12-31 2018-07-10 Abbott Lab composições nutricionais compreendendo oligossacarídeos e nucleotídeos de leite humano e usos destas para tratar e/ou prevenir infecção viral entérica.
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
US9795623B2 (en) 2010-12-31 2017-10-24 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin C and anti-inflammatory agents
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MY165628A (en) 2010-12-31 2018-04-18 Abbott Lab Human milk oligosaccharides for modulating inflammation
CN107595860A (zh) 2011-07-22 2018-01-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
RU2620370C2 (ru) * 2011-12-14 2017-05-25 Нестек С.А. Эмульгированный пищевой продукт, содержащий молочный белок
WO2014194053A2 (en) * 2013-05-29 2014-12-04 Siamab Therapeutics, Inc. Carbohydrate compounds for nutritional and therapeutic use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) * 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
DD273543A3 (de) * 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
ATE83611T1 (de) * 1988-07-07 1993-01-15 Milupa Ag Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
JP2673828B2 (ja) * 1989-04-19 1997-11-05 雪印乳業株式会社 κ―カゼイングリコマクロペプチドの製造法
CH681543A5 (zh) * 1990-04-27 1993-04-15 Nestle Sa
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
US5670201A (en) * 1991-06-21 1997-09-23 Snow Brand Milk Co., Ltd. Low allergenic nutrient composition and method of using same
AU5896194A (en) * 1992-10-30 1994-05-24 Cancer Research Fund Of Contra Costa Anti-diarrheic product and method of treating rotavirus-associated infection
US5576300A (en) * 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
NZ334319A (en) * 1996-08-30 2000-05-26 Nestle Sa Nutritional formula for phenylketonuria patients comprising a mixture of caesino-glyco-macropeptide and complementary essential amino acids other than Phe
WO1998014071A1 (en) * 1996-10-01 1998-04-09 John Stephen Ayers Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5 %w/w
US5968586A (en) * 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds

Also Published As

Publication number Publication date
WO2006118701A1 (en) 2006-11-09
US20060246146A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
TW200715996A (en) Method of increasing the salivary sialic acid content in a mammal
MY162096A (en) Method of improving learning and memory in mammals
AR082093A1 (es) Eliminacion de serina proteasas por tratamiento con dioxido de silicona finamente dividido
TW200700092A (en) Tigecycline compositions and methods of preparation
AR056816A1 (es) Composicion con ácido docosapentenoico
AR125991A2 (es) Preparación farmacéutica
WO2007005300A3 (en) Treatment of dry eye
RU2013134126A (ru) Способ снижения уровня с-концевого телопептида коллагена 2 типа
MX2010008633A (es) Ruptura de tolerancia inmunologica con un aminoacido no natural geneticamente codificado.
MX2007005519A (es) Cemento resistente a la compresion mejorado.
ATE445709T1 (de) Glycoproteinsynthese
EA200801460A1 (ru) Рекомбинантные моновалентные антитела и способы их получения
PT2135091E (pt) Métodos de ms para avaliar glicanos
MY156349A (en) Cleaning compositions and methods
MX2011009852A (es) Metodos para prevenir episodios cardiovasculares adversos mayores con inhibidores de dipeptidil peptidasa iv.
SG170086A1 (en) Modified molecules which promote hematopoiesis
MX2008002668A (es) Aditivo de productos alimenticios para el aporte de minerales.
WO2009124294A3 (en) Pharmaceutical compositions for binding sphingosine-1-phosphate
EA200801297A1 (ru) Способ снижения уровня постпрандиальной глюкозы
MX341064B (es) Variantes de la familia il-1.
WO2009015382A3 (en) Novel peptides that enhance tight junction permeability
MX2010000979A (es) Metodos y composiciones para tratar enfermedad autoinmune.
WO2008155651A3 (en) Inositol for induction of ovulation
WO2009143367A3 (en) Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders
WO2008021896A3 (en) Therapeutic methods for neuropathic pain